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Abstract
Introduction The assessment of adrenal function in critically ill
patients is problematic, and there is evidence to suggest that
measurement of tissue glucocorticoid activity may be more
useful than estimation of plasma cortisol concentrations.
Interstitial cortisol concentrations of cortisol represent the
available pool of glucocorticoids able to enter the cell and bind
to the glucocorticoid receptor. However the concentrations of
plasma cortisol may not accurately reflect interstitial
concentrations. We elected to perform a preliminary study into
the feasibility of measuring interstitial cortisol by microdialysis,
and to investigate the relationship between total plasma cortisol,
free plasma cortisol and interstitial cortisol in patients with
severe burns.
Methods A prospective observational study carried out in a
tertiary intensive care unit. Ten adult patients with a mean total
burn surface area of 48% were studied. Interstitial cortisol was
measured by microdialysis from patient-matched burnt and non-
burnt tissue and compared with that of 3 healthy volunteers.
Plasma sampling for estimations of total and free cortisol
concentrations was performed concurrently.
Results In the burn patients, mean total plasma and free plasma
cortisol concentrations were 8.8 +/- 3.9, and 1.7 +/- 1.1 mcg/
dL, (p < 0.001), respectively. Mean subcutaneous microdialysis
cortisol concentrations in the burn and non-burn tissue were
0.80 +/- 0.31 vs 0.74 +/- 0.41 mcg/dL (p = 0.8), respectively,
and were significantly elevated over the mean subcutaneous
microdialysis cortisol concentrations in the healthy volunteers.
There was no significant correlation between total plasma or
free plasma and microdialysis cortisol concentrations. Plasma
free cortisol was better correlated with total burn surface area
than total cortisol.
Conclusions In this preliminary study, interstitial cortisol
concentrations measured by microdialysis in burnt and non-
burnt skin from patients with severe thermal injury are
significantly elevated over those from healthy volunteers. Plasma
estimations of cortisol do not correlate with the microdialysis
levels, raising the possibility that plasma cortisol may be an
unreliable guide to tissue cortisol activity.
Introduction
The severely burned patient suffers from a rapidly changing
pathophysiology in the immediate post-burn period character-
ized by wound inflammation, cardiopulmonary instability, sys-
temic inflammatory response syndrome and metabolic
derangement. One of the integral components of this stress
response is the activation of the adrenal axis resulting in an
exaggerated output of cortisol. A number of studies have dem-
onstrated increases in total plasma cortisol and adrenocortico-
trophic hormone (ACTH) concentrations in the days following
thermal injury [1-3]. Urinary free cortisol levels have also been
shown to be increased after burns for up to 100 days [4]. All
of these changes would support the concept of an exagger-
ated adrenal response.
ACTH: adrenocorticotrophic hormone; CBG: cortisol binding globulin; ELISA: enzyme linked immunosorbent assay; GC: glucocorticoids; MDB: 
microdialysis concentrations from burn tissue; MDNB: microdialysis concentrations from non-burned tissue; PFC: plasma free cortisol; SD: standard 
deviation; TBSA: total burn surface area; TC: total cortisol.Critical Care    Vol 13 No 6    Cohen et al.
Page 2 of 7
(page number not for citation purposes)
However, attempting to characterise the sufficiency of the
adrenal response in this patient population has been problem-
atic. Patients with burns pose specific problems with respect
to the interpretation of adrenal function tests. The predominant
focus of previous investigations has been total plasma cortisol
(TC), yet it is the unbound, free cortisol that is the active frac-
tion [5]. Cortisol binding globulin (CBG) levels are known to
show significant variation following thermal injury and this will
therefore impact on the levels of physiologically active cortisol
[6]. Furthermore, total cortisol levels have been shown to be
subject to significant hourly variability and inter assay variation
[7,8]. Additionally, interpretation of stimulation tests in the set-
ting of the severe pre-existing stress of a burn injury is difficult,
because there is evidence that circulating endogenous ACTH
levels will influence the cortisol response to exogenous ACTH
[9].
Relevance of interstitial cortisol measurements
Given the above difficulties, more recent investigation of adre-
nal function in the critically ill has examined the role of plasma
free cortisol (PFC) [5,10] and tissue cortisol activity [11]. PFC
is the bioactive fraction and is a critical determinant of tissue
cortisol. However, plasma values are not the only determinant
of interest. Free cortisol exerts its activity by passing through
the cell membrane and binding to the cytosolic glucocorticoid
receptor. Due to their lipophilic nature glucocorticoids pas-
sively diffuse through plasma membranes [12] and thus it is
the free cortisol concentration in the interstitial fluid that is one
of the principal determinants of the available glucocorticoid
pool for receptor binding. Cortisol concentrations in plasma
and interstitial fluid may not necessarily run in parallel and
blood plasma to interstitial fluid exchange may be often com-
pound specific. For example, we have shown that there is a
significant dissociation between plasma and interstitial con-
centrations of antibiotics [13].
Microdialysis is an in vivo sampling technique for measuring
endogenous and exogenous solutes in the extracellular space
of tissue. A small probe equipped with a semi-permeable hol-
low fibre is inserted superficially into the dermis, and perfused
with a solution that forms an equilibrium with diffusible mole-
cules in the immediate surroundings [14]. Microdialysis tech-
niques have recently been used to investigate interstitial
cortisol concentrations (which are largely free) [15], thus
allowing comparison with plasma values. Although routine
measurement of tissue hormone concentrations may not be
practical in the clinical setting, the assessment of a relation
between plasma and interstitial concentrations may allow us to
develop predictive models for tissue cortisol concentrations
from plasma measurements.
The aims of this pilot study were: to examine the practicality
and feasibility of using microdialysis techniques to estimate
interstitial cortisol concentrations in patients with severe
burns; and to examine the relation between circulating TC and
PFC levels and interstitial cortisol.
Materials and methods
Study design
The plasma and microdialysis data for this study were
obtained in conjunction with a separate study investigating
antibiotic pharmacokinetics [13].
A burn site- and patient-matched paired comparison of burnt
and non-burnt tissue cortisol microdialysate levels was con-
ducted together with a non-paired comparison of microdia-
lysate levels from non-burnt tissue sites in burn patients and
healthy volunteers. Corresponding unbound plasma cortisol
concentrations were obtained simultaneously.
Ethical review
The protocol received approval from the Royal Brisbane Hos-
pital and University of Queensland Human Research Ethics
Committees. Written informed consent was obtained from the
legal guardians of enrolled patients and from the healthy volun-
teers.
Patient and volunteer enrolment
Ten adult patients with a mean ± standard deviation (SD) age
of 32 ± 11 years and total burn surface area (TBSA) of 48 ±
15% were enrolled in the study. The patients were admitted to
the Royal Brisbane & Women's Hospital intensive care unit
between February 2005 and February 2006 and received
eschar debridement and grafting surgery within the first few
days post-injury, during which time the studies were con-
ducted. Exclusion criteria included age younger than 18 years,
existing bacterial infection and known infection with hepatitis
A, B or C or HIV. Patients were resuscitated during the burn
shock phase using the Parkland formula adjusted to patients'
requirements [16]. No patients had been on chronic steroid
therapy prior to enrollment or received etomidate or hydrocor-
tisone during the period of the study. Inotropic or vasopressor
support was instituted at the treating clinicians' discretion.
Three volunteers with a mean ± SD age of 35 ± 5 years were
recruited exclusively from within the research group associ-
ated with the study. Exclusion criteria included age younger
than 18 years or poor health as assessed by a medical practi-
tioner.
Burn patient and healthy volunteer study protocols
Patient studies were conducted during debridement and graft-
ing procedures within five days of trauma (mean post-trauma
delay before grafting: 2.2 ± 1.2 days; mean surgery duration:
5.7 ± 1.9 hours). Burn patient microdialysis sites were
selected for anticipated ease of access during debridement
surgery in body areas that were not expected to be required
as skin graft donor sites, and were not scheduled for eschar
debridement at this procedure. Full thickness burn sites andAvailable online http://ccforum.com/content/13/6/R189
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adjacent non-burnt skin areas in the neck/shoulder and groin/
thigh areas were used. After insertion, probes were held in
place with a surgical stitch, and were then covered with pro-
tective sterile gauze and stapled to avoid dislodgment during
the debridement procedure in the operating theatre. The
microdialysis site for volunteers was the volar forearm. Patient
and volunteer microdialysis sites were anaesthetised with 1%
lignocaine (Xylocaine®, AstraZeneca, Luton, UK) before probe
insertion. The probe was held in place with Tegaderm™ (3 M
Health Care, St Paul, MN, USA). CMA 60 microdialysis
probes (CMA, Stockholm, Sweden) were perfused with asep-
tically prepared 0.9% saline containing 2 mg/L cefazolin at a
flow rate of 1.6 μL per minute from a 1 mL syringe using a
Graseby® MS16 24 h syringe driver (Smiths Group plc, Lon-
don, UK). Microdialysis probes were perfused for up to 30
minutes prior to insertion to remove the preservative buffer.
Probe perfusate was collected into sterile CMA collection
vials, transferred to reduced volume 300 μL polypropylene
autosampler vials (AH0-7777, Phenomenex, Torrance, CA,
USA) and stored at -20°C. Cortisol concentrations were
determined in 20 minute microdialysate collections that were
taken 5.3 ± 2.1 hours after commencement of surgery.
Cortisol analysis
Cortisol analysis was by ELISA using a commercial kit (Corti-
sol assay # KGE008, R&D Systems Inc, Minneapolis, MN,
USA) in exact accordance with the manufacturer's instruc-
tions. Briefly, the assay employs competitive ELISA principles
in a 96-well plate and has a horseradish peroxidise/3,3',5,5'-
tetramethylbenzidine endpoint read at 450 nm λ with wave-
length correction at 540 nm λ. We used a Paradigm™ Detec-
tion Platform and Multimode Analysis Software version 3.1.0.1
(Beckman Coulter Inc, Fullerton, CA, USA) for quantification.
In our study the ELISA gave an inter-assay coefficient of varia-
tion (CV) of 6.36% (for 2.5 ng/mL on five occasions) and a
dynamic range of 0.312 to 10 ng/mL cortisol. A linear ELISA
response to cortisol dilution with saline was demonstrated.
Sample dilution
All samples required dilution prior to ELISA analysis to ensure
that their cortisol values could be read from the standard
curve. Unprocessed plasma samples were all diluted 1/20 in
accordance with the manufacturer's instructions. Ultracentri-
fuged plasma samples were diluted 1/5 and 1/2. For microdi-
alysis samples a dilution factor of 1/3 was optimal for 68% of
analyses. Additional dilution factors were required for six
microdialysis samples.
Unbound plasma cortisol determination
Blood was sampled into heparinised vacutainers® (BD, Beck-
ton-Dickinson, Rutherford NJ, USA) from an indwelling arterial
cannula for patients and from an indwelling venous cannula for
volunteers, processed and stored at -20°C. Patient plasma
sample times differed to microdialysis sample times by 0.7 ±
0.6 hours. Ultracentrifugation methods were used to isolate
unbound plasma cortisol fractions. Briefly, 500 μL of plasma
was incubated at 37°C for 30 minutes and ultracentrifuged at
12,000 g for 20 minutes through 30 KDa nominal cut-off mem-
brane devices (Amicon® YM30, Millopore Corporation, Biller-
ica, MA, USA) to give a filtrate yield of approximately 25%
original volume that was analysed by cortisol ELISA.
Statistical analysis
Continuous, normally distributed variables were summarised
as mean ± SD. Differences in cortisol concentrations between
groups were analysed using independent t-tests. The degree
of association between variables was assessed using Spear-
man's correlation coefficient. Statistical significance was
taken at a level of 5%.
Results
Thirteen subjects were enrolled into the study; 10 burns
patients and three healthy volunteers. Demographic data for
the burns patients are presented in Table 1. Of these patients,
80% were male, with an average age of 32 ± 11 years and
TBSA of 48 ± 15%.
Plasma and microdialysis values are presented in Table 2. Two
plasma and one microdialysis sample from patients six and
nine were unsuitable for analysis.
Mean TC and PFC concentrations were 8.8 ± 3.9 and 1.7 ±
1.1 μg/dL (P < 0.001), respectively. Mean microdialysis corti-
sol concentrations in the burn (MDB) and non-burn tissue
(MDNB) were 0.80 ± 0.31 vs 0.74 ± 0.41 μg/dL (P = 0.8),
respectively.
Table 1
Patient demographics
Patient number APACHE II Burn area (%)
11 4 5 3
21 5 3 5
31 5 4 5
49 3 0
51 3 2 8
69 4 5
71 3 7 0
81 1 4 5
98 4 0
10 13 65
APACHE = acute physiology and chronic health evaluation.Critical Care    Vol 13 No 6    Cohen et al.
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TC was significantly elevated with respect to both the MDB
and MDNB concentrations (P < 0.001); however, PFC was
significantly elevated over MDNB cortisol (1.7 ± 1.1 vs 0.74 ±
0.41; P = 0.05) but not MDB (1.7 ± 1.1 vs 0.80 ± 0.31, P =
0.06).
Compared with the healthy controls both the MBD and MBNB
cortisol concentrations were significantly elevated; 0.80 ±
0.31 and 0.74 ± 0.41 vs 0.20 ± 0.05 μg/dL (P = 0.003, P =
0.004), respectively.
Correlative analysis
We examined the correlation between TC and PFC concentra-
tions, MCB and MDNB concentrations, and TBSA. Overall,
there were no statistically significant correlations.
TC was well correlated with PFC (r = 0.59) but less well cor-
related with MDB (r = 0.3). Similarly, the correlation between
PFC and MDB was poor (r = 0.2). This poor correlation was
reflected in the observation that 20% of the MDB concentra-
tions were higher than the corresponding plasma PFC values.
TC and PFC, MDB and MDNB values are presented in Figure
1.
TBSA was correlated best with the plasma PFC concentration
(r = 0.54), and less so with the TC (r = 0.46) and MBD (r =
Table 2
Plasma and tissue cortisol measurements
Patient number Total plasma cortisol 
(μg/dl)
Free plasma cortisol 
(μg/dl)
Microdialysis cortisol 
burn tissue (μg/dl)
Microdialysis cortisol 
non-burn tissue (μg/dl)
Requiring 
vasopressors
1 10.7 3.4 0.4 0.3 No
23 . 0 0 . 3 0 . 5 0 . 1 N o
3 12.0 2.4 0.8 1.0 No
42 . 2 0 . 1 0 . 5 0 . 5 Y e s
5 11.0 1.4 1.2 0.7 Yes
61 . 3 1 . 1 N o
77 . 2 1 . 3 1 . 2 1 . 6 N o
8 11.1 1.9 0.6 0.8 Yes
94 . 5 Y e s
10 13.2 3.1 1.3 0.8 Yes
Volunteer Microdialysis cortisol 
(μg/dl)
10 . 3
20 . 2
30 . 1
Figure 1
Plasma and interstitial cortisol values Plasma and interstitial cortisol valuesAvailable online http://ccforum.com/content/13/6/R189
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0.35). However, there was a better correlation between
MDNB and TBSA (r = 0.54).
Discussion
To the best of our knowledge, this is the first study to examine
interstitial cortisol concentrations in a critically ill population
suffering from severe burns. We have demonstrated the feasi-
bility of measuring interstitial cortisol concentrations in
patients with burns. Our preliminary data also indicate that
interstitial cortisol levels are significantly elevated over normal
controls, and that there is no significant correlation between
free cortisol and microdialysis cortisol concentrations taken
from either burned or non-burned tissue. As can be seen from
Figure 1 in several cases microdialysis concentrations were
higher than those of plasma.
Glucocorticoids (GC) are known to play an essential role in
the response to critical illness. Although absolute adrenal
insufficiency is a well recognised, but rare, clinical entity, rela-
tive adrenal insufficiency (or critical illness-related corticoster-
oid insufficiency) is a less well-recognised phenomenon, in
which it is postulated that there may be a blunted adrenal
response to stress or a tissue resistance to GC action. Identi-
fication of patients with this syndrome is of clinical importance,
because they may potentially benefit from cortisol supplemen-
tation in the form of hydrocortisone; however, results from clin-
ical trials of hydrocortisone in the setting of septic shock have
been inconclusive [17,18], which may be in part due to an ina-
bility to effectively measure adrenal function in this patient
population. Previous diagnostic criteria have been primarily
focused on the measurement of TC values, taken either as a
random baseline or as part of a stimulation test in response to
synthetic ACTH. However, TC measurement has a number of
drawbacks including: poor correlation with the active, free hor-
mone concentrations; poor reproducibility; significant hourly
fluctuations; and significant intra-assay variations
[5,7,8,10,19]. Recognition of these limitations has led to the
recommendations in the latest surviving sepsis guidelines that
plasma cortisol values should not be used for the identification
of patients with potential adrenal insufficiency [20].
Previous studies in burns patients have demonstrated eleva-
tions of TC, but these have been highly variable ranging from
average concentrations of 12.4 to 32 μg/dL [21,22]. The rela-
tion between TBSA and TC is also unclear, because some
investigators have been able to demonstrate a correlation [2],
while others have not [21].
Investigations into PFC levels in burns have been more limited
[6,23] but likewise suggest that PFC levels are initially
increased after burn injury.
In our study the TC levels were surprisingly low, (8.8 ± 3.9 μg/
dL) for the degree of stress and indeed fall into the range
observed in healthy volunteers [5]. However, TC values in this
range have been reported in other studies [11,24,25]. In con-
trast, the PFC values were elevated over the normal reference
range [5]. However, the PFC concentrations in burns patients
reported by Bernier and colleagues [6], range between 12 and
16 μg/dL, which are significantly higher than those seen in our
patients, and in those reported in septic shock [5,10]. There
are a number of possible reasons for this discrepancy. TC val-
ues in burns patients may be influenced by numerous factors,
including time of sampling, TBSA, CBG levels, effect of resus-
citation, and general anaesthesia. It is noteworthy that our
samples were taken on average several days after the injury,
and during surgical debridement. General anaesthesia, time
after burn injury, blood transfusion in the setting of surgery,
and differing resuscitation protocols may all have significant
effects on our measured cortisol values. In addition, our results
indicated that PFC was better correlated with TBSA than TC.
To our knowledge this observation has not been made before,
and is consistent with studies in sepsis indicating that PFC is
more closely correlated with sickness severity than TC [10].
A potentially more accurate estimation of adrenal axis function
may come from examining tissue GC activity. The interstitial
cortisol concentration represents the available GC pool, which
is able to enter the cell and bind to the GC receptor. As such,
it is therefore a more accurate marker of tissue cortisol activity
than plasma concentrations. However, the reference range for
interstitial cortisol in the critically ill patient is unknown. It has
historically been assumed that TC concentrations determine
PFC concentrations which in turn determine interstitial cortisol
concentrations; the so called 'cortisol cascade'. We have
demonstrated that interstitial cortisol concentrations are sig-
nificantly elevated in both burnt and non-burnt tissue from
patients with severe thermal injury, and that the correlation
between interstitial and plasma concentrations of cortisol is
poor. It is particularly noteworthy that in 20% of cases, micro-
dialysis cortisol concentrations from burned tissue were
higher than the corresponding plasma values.
There are a number of possible explanations for these findings,
including generation of interstitial free cortisol, diffusion of
intracellular cortisol, and local pharmacokinetic factors.
Cortisol can be cleaved from cortisol binding globulin by the
actions of neutrophil elastase, an enzyme released from poly-
morphonuclear leukocytes at the site of inflammation [26]. The
extensive inflammatory response engendered by severe burn
injury may therefore lead to increased interstitial cortisol con-
centrations via this mechanism. Additionally, intracellular corti-
sol, generated from cortisone secondary to the activity of 11
betahydroxysteroid dehydrogenase 1 enzyme, can diffuse into
the interstitium [15], thus contributing to the interstitial pool of
free cortisol.
Other factors may influence interstitial cortisol concentrations.
These include interstitial fluid volume, capillary 'leakage' andCritical Care    Vol 13 No 6    Cohen et al.
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peripheral tissue perfusion, all of which are likely to be signifi-
cantly abnormal in patients with severe burns. Extensive tissue
oedema is characteristic of severe thermal injury, and appears
to be related to increased capillary permeability, vigorous fluid
resuscitation, and changes in interstitial fluid pressure [27].
Increased capillary permeability has been documented to
increase in both burned and non-burned tissue following ther-
mal injury [28], which may explain the lack of difference in
MDB and MDNB cortisol concentrations in our group. Vaso-
pressor use is also frequent in the management of serious
burns, and the subsequent vasoconstriction can reduce tissue
perfusion, thus potentially reducing cortisol clearance. Of note
was that 50% of our subjects were receiving noradrenaline
infusions at the time of enrolment.
Similar pathophysiological changes to those of burns can be
observed in subjects suffering from trauma or severe sepsis,
and studies in these groups have demonstrated significant var-
iations in the interstitial concentrations of antibiotics com-
pared with healthy controls [29,30].
Our study has a number of limitations, primarily it has a limited
sample size. We did not perform ACTH testing, because the
rapidly changing physiology of the operative setting would
make the results difficult to interpret. Moreover, as noted ear-
lier, stimulation testing in critically ill patients is subject to a
number of errors. We are also unable to comment as to
whether the divergence between plasma and interstitial values
we have demonstrated in skin would be replicated in other tis-
sues. However, our intent was that of hypothesis generation
into cortisol kinetics in the critically ill patient as a platform for
planning future trials.
Conclusions
In this preliminary study, we have shown that microdialysis
techniques can be used to estimate interstitial cortisol con-
centrations in critically ill patients. Plasma estimations of corti-
sol do not correlate with the microdialysis levels raising the
possibility that plasma cortisol may be an unreliable guide to
tissue cortisol activity.
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